Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term double-blind comparison of gliclazide MR vs rosiglitazone in combination with metformin in type 2 diabetes
2006-001240-30Phase 3Completed
- Sponsor
- Servier
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Gliclazide MR + metformin with Rosiglitazone (Avandia) + metformin (2 arms). Primary endpoints: Weighted mean HbA1c over time and HbA1c at different periods. Started Aug 2006; status: completed.
02
Drugs
rosiglitazonegliclazidemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-001240-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001240-30.